256 related articles for article (PubMed ID: 23053330)
1. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
2. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
4. Genetics and genomics of pseudoexfoliation syndrome/glaucoma.
Schlötzer-Schrehardt U
Middle East Afr J Ophthalmol; 2011 Jan; 18(1):30-6. PubMed ID: 21572731
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
[TBL] [Abstract][Full Text] [Related]
6. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
7. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases.
Anastasopoulos E; Founti P; Topouzis F
Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
10. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
[TBL] [Abstract][Full Text] [Related]
11. [Oxidative stress and pseudoexfoliation glaucoma].
Schlötzer-Schrehardt U
Klin Monbl Augenheilkd; 2010 Feb; 227(2):108-13. PubMed ID: 20155654
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
[TBL] [Abstract][Full Text] [Related]
13. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
Zenkel M
J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
[TBL] [Abstract][Full Text] [Related]
15. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
16. Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms.
Schlötzer-Schrehardt U; Khor CC
Curr Opin Ophthalmol; 2021 Mar; 32(2):118-128. PubMed ID: 33332884
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression in pseudoexfoliation syndrome.
Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
[TBL] [Abstract][Full Text] [Related]
19. The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome.
Berner D; Hoja U; Zenkel M; Ross JJ; Uebe S; Paoli D; Frezzotti P; Rautenbach RM; Ziskind A; Williams SE; Carmichael TR; Ramsay M; Topouzis F; Chatzikyriakidou A; Lambropoulos A; Sundaresan P; Ayub H; Akhtar F; Qamar R; Zenteno JC; Cruz-Aguilar M; Astakhov YS; Dubina M; Wiggs J; Ozaki M; Kruse FE; Aung T; Reis A; Khor CC; Pasutto F; Schlötzer-Schrehardt U
Hum Mol Genet; 2019 Aug; 28(15):2531-2548. PubMed ID: 30986821
[TBL] [Abstract][Full Text] [Related]
20. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
